Evidence map›Paper›PMID 32977686›Full record

ArticleBiomedicines2020

Glutathione-Stabilized Silver Nanoparticles: Antibacterial Activity against Periodontal Bacteria, and Cytotoxicity and Inflammatory Response in Oral Cells.

Irene Zorraquín-Peña, Carolina Cueva, Dolores González de Llano, Begoña Bartolomé, M Victoria Moreno-Arribas

Abstract read
In one paragraph

Article in Biomedicines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Green-SynthesizedJournal of functional biomaterials · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Hydrothermally synthesized silver-decorated propolis quantum dots: a dual-action antibacterial and antioxidant nanocomposite.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Emerging strategies for combatingExploration (Beijing, China) · 2024
    Review
  13. Review
  14. Article
  15. Bacterial-Mediated Tumor Therapy: Old Treatment in a New Context.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Irene Zorraquín-PeñaInstitute of Food Science Research (CIAL), CSIC-UAM, C/Nicolás Cabrera, 9, Campus de Cantoblanco, 28049 Madrid, Spain.
Carolina CuevaInstitute of Food Science Research (CIAL), CSIC-UAM, C/Nicolás Cabrera, 9, Campus de Cantoblanco, 28049 Madrid, Spain.
Dolores González de LlanoInstitute of Food Science Research (CIAL), CSIC-UAM, C/Nicolás Cabrera, 9, Campus de Cantoblanco, 28049 Madrid, Spain.ORCID 0000-0002-6394-4039
Begoña BartoloméInstitute of Food Science Research (CIAL), CSIC-UAM, C/Nicolás Cabrera, 9, Campus de Cantoblanco, 28049 Madrid, Spain.ORCID 0000-0002-4470-251X
M Victoria Moreno-ArribasInstitute of Food Science Research (CIAL), CSIC-UAM, C/Nicolás Cabrera, 9, Campus de Cantoblanco, 28049 Madrid, Spain.ORCID 0000-0002-4136-595X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silver nanoparticles (AgNPs) have been proposed as new alternatives to limit bacterial dental plaque because of their antimicrobial activity. Novel glutathione-stabilized silver nanoparticles (GSH-AgNPs) have proven powerful antibacterial properties in food manufacturing processes. Therefore, this study aimed to evaluate the potentiality of GSH-AgNPs for the prevention/treatment of oral infectious diseases. First, the antimicrobial activity of GSH-AgNPs against three oral pathogens (

Indexed as

antimicrobial activitycytokinescytotoxicityoral bacteriaperiodontal pathogenssilver nanoparticles

Identifiers

PMID32977686
PMCPMC7598685

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.